DURECT Corp (DRRX.OQ)
DRRX.OQ on NASDAQ Stock Exchange Global Market
1.26USD
1 Aug 2013
1.26USD
1 Aug 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.26
$1.26
Open
$1.25
$1.25
Day's High
$1.29
$1.29
Day's Low
$1.24
$1.24
Volume
9,453
9,453
Avg. Vol
123,188
123,188
52-wk High
$1.85
$1.85
52-wk Low
$0.61
$0.61
About
Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New... (more)
Overall
| Beta: | 1.28 |
| Market Cap (Mil.): | $128.39 |
| Shares Outstanding (Mil.): | 101.89 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DRRX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.22 | -- | -- |
| ROI: | -53.40 | -2.58 | 18.76 |
| ROE: | -57.01 | -2.66 | 19.59 |
Pain Therapeutics, Durect shares soar on Pfizer's Remoxy comments
- Shares of Pain Therapeutics Inc and Durect Corp rose more than 40 percent after partner Pfizer Inc said it is in talks with U.S. health regulators to find a way forward on the companies' painkiller, Remoxy.
Competitors
| Price | Change | |
|---|---|---|
| HISAMITSU PHARMACEUTICAL CO., INC. (4530.T) | ¥5,480 | +80.00 |
| Johnson & Johnson (JNJ.N) | $93.84 | +0.34 |
| Pfizer Inc. (PFE.N) | $29.19 | -0.04 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| AstraZeneca plc (AZN.L) | 3,315.50p | -19.50 |
| Eli Lilly & Co. (LLY.N) | $53.24 | +0.13 |
| Kimberly Clark Corp (KMB.N) | $98.80 | 0.00 |
| Bristol Myers Squibb Co. (BMY.N) | $43.83 | +0.59 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Medtronic, Inc. (MDT.N) | $55.37 | +0.13 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

